Autoimmune diabetes is characterized by the selective destruction of ?-cells that occurs during an inflammatory reaction in and around pancreatic islets. Inflammatory cytokines, released during this process, impair ?-cell function and can induce ?-cell death. Cytokines have also been implicated in the loss of functional ?-cell mass during the development of type 2 diabetes. The broad goals of this research are to elucidate the cellular mechanisms that are responsible the functional impairment and death of pancreatic ?-cell following cytokine treatment, and to identify pathways by which ?-cells protect themselves against cytokine-mediated damage. Reactive nitrogen species (RNS;e.g., nitric oxide) are primary mediators of the damaging actions of interleukin-1 (IL-1) and interferon (IFN)-??on ?-cell function and viability. We have shown that nitric oxide can also activate "protective pathways" that lead to the recovery of insulin secretory function, mitochondrial oxidative metabolism, and the repair of damaged DNA. It is the delicate balance between the toxic and protective actions of RNS, produced by ?-cells in response to cytokines that ultimately determines whether these cells survive or die. This proposal will elucidate the pathways that control ?-cell fate following cytokine treatment. There are three specific aims: 1) To test the hypothesis that the response of ?-cells to cytokine treatment is determined by a) the form of reactive oxygen species (ROS) or reactive nitrogen species (RNS) produced, and b) the ability of ROS and RNS to selectively regulate signaling cascades that control cellular repair/protective pathways or activate cell death cascades;2) To test the hypothesis that Ataxia telangiectasia mutated (ATM) plays a primary role in regulating the response(s) of ?-cells to cytokine- and nitric oxide-mediated damage;3) To test the hypothesis that the activation status of SIRT1 determines whether ?-cells respond to cytokine treatment with the induction of "protective pathways" or the stimulation of cell death cascades. A number of biochemical, molecular, immunological, cell biological and transgenic techniques will be utilized to investigate the cellular pathways through which nitric oxide and its reactive intermediates mediate ?-cell damage and the pathways that participate in the protection of ?-cells from cytokine-induced damage. It is hoped that insights into the mechanisms controlling the response of ?-cells to cytokines that are gained from these studies will influence the design of therapeutic strategies aimed at attenuating the loss of functional ?-cell mass during the development of diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK052194-18A1
Application #
8654239
Study Section
Special Emphasis Panel (ZRG1-EMNR-T (02))
Program Officer
Appel, Michael C
Project Start
1998-01-01
Project End
2018-03-31
Budget Start
2014-04-02
Budget End
2015-03-31
Support Year
18
Fiscal Year
2014
Total Cost
$359,550
Indirect Cost
$124,550
Name
Medical College of Wisconsin
Department
Biochemistry
Type
Schools of Medicine
DUNS #
937639060
City
Milwaukee
State
WI
Country
United States
Zip Code
53226
Hye Khan, Md Abdul; Hwang, Sung Hee; Sharma, Amit et al. (2016) A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat. Prostaglandins Other Lipid Mediat 125:40-7
Elrick, Mollisa M; Samson, Willis K; Corbett, John A et al. (2016) Neuronostatin acts via GPR107 to increase cAMP-independent PKA phosphorylation and proglucagon mRNA accumulation in pancreatic α-cells. Am J Physiol Regul Integr Comp Physiol 310:R143-55
Oleson, Bryndon J; Broniowska, Katarzyna A; Naatz, Aaron et al. (2016) Nitric Oxide Suppresses β-Cell Apoptosis by Inhibiting the DNA Damage Response. Mol Cell Biol 36:2067-77
Oleson, Bryndon J; McGraw, Jennifer A; Broniowska, Katarzyna A et al. (2015) Distinct differences in the responses of the human pancreatic β-cell line EndoC-βH1 and human islets to proinflammatory cytokines. Am J Physiol Regul Integr Comp Physiol 309:R525-34
Shaheen, Zachary R; Naatz, Aaron; Corbett, John A (2015) CCR5-Dependent Activation of mTORC1 Regulates Translation of Inducible NO Synthase and COX-2 during Encephalomyocarditis Virus Infection. J Immunol 195:4406-14
Broniowska, Katarzyna A; Mathews, Clayton E; Corbett, John A (2015) Reply to Gurgul-Convey and Lenzen: Cytokines, nitric oxide, and β-cells. J Biol Chem 290:10571
Kropp, Erin M; Oleson, Bryndon J; Broniowska, Katarzyna A et al. (2015) Inhibition of an NAD⁺ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells. Stem Cells Transl Med 4:483-93
Shaheen, Zachary R; Corbett, John A (2015) Macrophage Expression of Inflammatory Genes in Response to EMCV Infection. Biomolecules 5:1938-54
Broniowska, Katarzyna A; Oleson, Bryndon J; McGraw, Jennifer et al. (2015) How the location of superoxide generation influences the β-cell response to nitric oxide. J Biol Chem 290:7952-60
Yosten, Gina L C; Elrick, Mollisa M; Salvatori, Alison et al. (2015) Understanding peptide biology: The discovery and characterization of the novel hormone, neuronostatin. Peptides 72:192-5

Showing the most recent 10 out of 67 publications